POS-282 ROXADUSTAT TREATMENT RESULTS IN CONSISTENT IMPROVEMENTS IN HEMOGLOBIN (HB) VERSUS PLACEBO: AN ANALYSIS OF THREE MULTINATIONAL RCTS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE (NDD-CKD)

• R. Pecoits Filho MD,
• T.M. Chan,
• E. Hardy,
• K.P. Yu,
• S. Fishbane

Affiliations

R. Pecoits Filho MD

Arbor Research Collaborative for Health, DOOPS Program, Ann Arbor, United States; School of Medicine- Pontifical Catholic University of Parana, None, Curitiba, Brazil

T.M. Chan

Queen Mary Hospital- The University of Hong Kong, Division of Nephrology- Department of Medicine, Pok Fu Lam, Hong Kong- China

E. Hardy

AstraZeneca, Clinical Research, Gaithersburg, United States

K.P. Yu

FibroGen Inc., None, San Francisco, United States

S. Fishbane

Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Department of Medicine, Great Heck, United States